Gennex Lab.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE509C01026
  • NSEID:
  • BSEID: 531739
INR
9.70
-0.25 (-2.51%)
BSENSE

Mar 13

BSE+NSE Vol: 4.82 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 930938,
    "name": "Gennex Lab.",
    "stock_name": "Gennex Lab.",
    "full_name": "Gennex Laboratories Ltd",
    "name_url": "stocks-analysis/gennex-lab",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "9.70",
    "chg": -0.25,
    "chgp": "-2.51%",
    "dir": -1,
    "prev_price": "9.95",
    "mcapval": "242.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531739,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE509C01026",
    "curr_date": "Mar 13",
    "curr_time": "",
    "bse_nse_vol": "4.82 lacs",
    "exc_status": "Active",
    "traded_date": "Mar 13, 2026",
    "traded_date_str": "2026 03 13",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/gennex-lab-930938-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Gennex Laboratories Ltd Stock Falls to 52-Week Low of Rs.9.61",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gennex-laboratories-ltd-stock-falls-to-52-week-low-of-rs961-3890247",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GennexLaborator_priceRelatedfactors_3890247.png",
        "date": "2026-03-13 19:59:59",
        "description": "Gennex Laboratories Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.9.61 today, marking a significant decline amid broader market weakness and sectoral underperformance."
      },
      {
        "title": "Gennex Laboratories Ltd Stock Falls to 52-Week Low of Rs.9.9",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gennex-laboratories-ltd-stock-falls-to-52-week-low-of-rs99-3887182",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GennexLaborator_priceRelatedfactors_3887182.png",
        "date": "2026-03-12 14:55:51",
        "description": "Gennex Laboratories Ltd’s stock declined to a fresh 52-week low of Rs.9.9 on 12 Mar 2026, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector and broader market weakness. The stock underperformed its sector and key indices, continuing a downward trend that has persisted over the past year."
      },
      {
        "title": "Gennex Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gennex-laboratories-ltd-is-rated-sell-3884955",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GennexLaborator_mojoScore_3884955.png",
        "date": "2026-03-11 10:10:03",
        "description": "Gennex Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Gennex Laboratories Ltd Stock Hits 52-Week Low at Rs.9.92",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gennex-laboratories-ltd-stock-hits-52-week-low-at-rs992-3882904",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GennexLaborator_priceRelatedfactors_3882904.png",
        "date": "2026-03-10 13:18:08",
        "description": "Gennex Laboratories Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.9.92 today, marking a significant decline amid broader market fluctuations and sectoral underperformance."
      },
      {
        "title": "Gennex Laboratories Ltd Stock Hits 52-Week Low at Rs.10.1",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gennex-laboratories-ltd-stock-hits-52-week-low-at-rs101-3880205",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GennexLaborator_priceRelatedfactors_3880205.png",
        "date": "2026-03-09 13:32:39",
        "description": "Gennex Laboratories Ltd’s shares declined sharply to a new 52-week low of Rs.10.1 on 9 March 2026, marking a significant downturn amid broader market weakness and company-specific performance concerns. The stock has underperformed its sector and the broader market over the past year, reflecting a challenging period for the pharmaceutical and biotechnology firm."
      },
      {
        "title": "Gennex Laboratories Ltd Falls to 52-Week Low of Rs.10.36",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gennex-laboratories-ltd-falls-to-52-week-low-of-rs1036-3864852",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GennexLaborator_priceRelatedfactors_3864852.png",
        "date": "2026-03-02 12:36:34",
        "description": "Gennex Laboratories Ltd’s shares declined to a fresh 52-week low of Rs.10.36 on 2 Mar 2026, marking a significant milestone in the stock’s downward trajectory over the past year. This new low reflects ongoing pressures within the Pharmaceuticals & Biotechnology sector and highlights the stock’s underperformance relative to broader market indices."
      },
      {
        "title": "Gennex Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gennex-laboratories-ltd-is-rated-sell-3857859",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/GennexLaborator_mojoScore_3857859.png",
        "date": "2026-02-26 10:10:03",
        "description": "Gennex Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 February 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Gennex Laboratories Declines 4.65%: Key Financial and Market Factors This Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gennex-laboratories-declines-465-key-financial-and-market-factors-this-week-3849636",
        "imagepath": "",
        "date": "2026-02-21 14:01:11",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>16 Feb:</strong> Flat quarterly performance reported with record sales and margin gains</p>\n                    <p><strong>17 Feb:</strong> Quality grade downgraded from good to average, Mojo Grade shifted to Sell</p>\n                    <p><strong>20 Feb:</strong> Stock closes the week at Rs.11.69, down 4.65% from previous Friday</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.12.26</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.11.69</div><div class=\"stat-change negative\">-4.65%..."
      },
      {
        "title": "Gennex Laboratories Ltd Quality Grade Downgrade: A Detailed Fundamental Analysis",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gennex-laboratories-ltd-quality-grade-downgrade-a-detailed-fundamental-analysis-3843187",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/GennexLaborator_qualitydot_3843187.png",
        "date": "2026-02-17 08:01:01",
        "description": "Gennex Laboratories Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its quality rating downgraded from good to average as of 19 Jan 2026. This shift reflects changes in key business fundamentals including return ratios, debt levels, and growth consistency, prompting a reassessment of its investment appeal amid a challenging market environment."
      }
    ],
    "total": 151,
    "sid": "930938",
    "stock_news_url": "https://www.marketsmojo.com/news/gennex-laboratories-930938"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "17-Feb-2026",
      "details": "Pursuant to Regulation 47 of SEBI (LODR) Regulations 2015 please find enclosed herewith Newspaper Publication on Unaudited (Standalone & Consolidated) Financial Results for the Quarter and Nine months ended December 31 2025 announced by the Board of Directors in its meeting held on Saturday February 14 2026. Financial Results had been published in both Business Standard (English) and Saksham ( Telugu-Local) on Monday February 16 2026. We request you to take the above information on record and acknowledge receipt of the same.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "14-Feb-2026",
      "details": "Pursuant to Regulation 30 read with Part A of Schedule III of SEBI (LODR) Regulations 2015 we would like to inform you that based on recommendation of Nomination and Remuneration Committee the Board of Directors approved the appointment of Ms. Khushboo Kachhawa (DIN#10872432) as an Additional (Non-Executive & Independent) Women Director of the Company with effect from February 14 2026 subject to approval of the shareholders of the Company. Ms Khushbu Kachhawa will be a Non-Executive & Independent Women Director and she is not related to Promoter or Promoter Group and fulfills the criteria as required under the provisions of the Companies Act 2013 and rules framed thereunder and Listing Regulations. The relevant details and disclosure under Form B enclosed herewith. We request you to take the above information on record and acknowledge the receipt of the same.",
      "source": "BSE"
    },
    {
      "caption": "Quarter And Nine Months Ended December 31 2025",
      "datetime": "14-Feb-2026",
      "details": "Unaudited (Standalone and Consolidated) Financial Results for 31.12.2025 along with Limited Review Report thereon.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Gennex Laboratories Ltd has announced <strong>1:10</strong> stock split, ex-date: 14 Dec 09",
          "dt": "2009-12-14",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Gennex Laboratories Ltd has announced <strong>1:2</strong> rights issue, ex-date: 21 Jul 22",
          "dt": "2022-07-21",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

17-Feb-2026 | Source : BSE

Pursuant to Regulation 47 of SEBI (LODR) Regulations 2015 please find enclosed herewith Newspaper Publication on Unaudited (Standalone & Consolidated) Financial Results for the Quarter and Nine months ended December 31 2025 announced by the Board of Directors in its meeting held on Saturday February 14 2026. Financial Results had been published in both Business Standard (English) and Saksham ( Telugu-Local) on Monday February 16 2026. We request you to take the above information on record and acknowledge receipt of the same.

Announcement under Regulation 30 (LODR)-Change in Management

14-Feb-2026 | Source : BSE

Pursuant to Regulation 30 read with Part A of Schedule III of SEBI (LODR) Regulations 2015 we would like to inform you that based on recommendation of Nomination and Remuneration Committee the Board of Directors approved the appointment of Ms. Khushboo Kachhawa (DIN#10872432) as an Additional (Non-Executive & Independent) Women Director of the Company with effect from February 14 2026 subject to approval of the shareholders of the Company. Ms Khushbu Kachhawa will be a Non-Executive & Independent Women Director and she is not related to Promoter or Promoter Group and fulfills the criteria as required under the provisions of the Companies Act 2013 and rules framed thereunder and Listing Regulations. The relevant details and disclosure under Form B enclosed herewith. We request you to take the above information on record and acknowledge the receipt of the same.

Quarter And Nine Months Ended December 31 2025

14-Feb-2026 | Source : BSE

Unaudited (Standalone and Consolidated) Financial Results for 31.12.2025 along with Limited Review Report thereon.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

Gennex Laboratories Ltd has announced 1:10 stock split, ex-date: 14 Dec 09

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

Gennex Laboratories Ltd has announced 1:2 rights issue, ex-date: 21 Jul 22